Harvey Lisa A, Katalinic Owen M, Herbert Robert D, Moseley Anne M, Lannin Natasha A, Schurr Karl
John Walsh Centre for Rehabilitation Research, Kolling Institute, Northern Sydney Local Health District, Royal North Shore Hospital, St Leonards, NSW, Australia, 2065.
Rehabilitation Studies Unit, Northern Clinical School, Sydney Medical School, The University of Sydney, PO Box 6, Ryde, NSW, Australia, 1680.
Cochrane Database Syst Rev. 2017 Jan 9;1(1):CD007455. doi: 10.1002/14651858.CD007455.pub3.
Contractures are a common complication of neurological and non-neurological conditions, and are characterised by a reduction in joint mobility. Stretch is widely used for the treatment and prevention of contractures. However, it is not clear whether stretch is effective. This review is an update of the original 2010 version of this review.
The aim of this review was to determine the effects of stretch on contractures in people with, or at risk of developing, contractures.The outcomes of interest were joint mobility, quality of life, pain, activity limitations, participation restrictions, spasticity and adverse events.
In November 2015 we searched CENTRAL, DARE, HTA; MEDLINE; Embase; CINAHL; SCI-EXPANDED; PEDro and trials registries.
We included randomised controlled trials and controlled clinical trials of stretch applied for the purpose of treating or preventing contractures.
Two review authors independently selected trials, extracted data, and assessed risk of bias. The outcomes of interest were joint mobility, quality of life, pain, activity limitations, participation restrictions and adverse events. We evaluated outcomes in the short term (up to one week after the last stretch) and in the long term (more than one week). We expressed effects as mean differences (MD) or standardised mean differences (SMD) with 95% confidence intervals (CI). We conducted meta-analyses with a random-effects model. We assessed the quality of the body of evidence for the main outcomes using GRADE.
Forty-nine studies with 2135 participants met the inclusion criteria. No study performed stretch for more than seven months. Just over half the studies (51%) were at low risk of selection bias; all studies were at risk of detection bias for self reported outcomes such as pain and at risk of performance bias due to difficulty of blinding the intervention. However, most studies were at low risk of detection bias for objective outcomes including range of motion, and the majority of studies were free from attrition and selective reporting biases. The effect of these biases were unlikely to be important, given that there was little benefit with treatment. There was high-quality evidence that stretch did not have clinically important short-term effects on joint mobility in people with neurological conditions (MD 2°; 95% CI 0° to 3°; 26 studies with 699 participants) or non-neurological conditions (SMD 0.2, 95% CI 0 to 0.3, 19 studies with 925 participants).In people with neurological conditions, it was uncertain whether stretch had clinically important short-term effects on pain (SMD 0.2; 95% CI -0.1 to 0.5; 5 studies with 174 participants) or activity limitations (SMD 0.2; 95% CI -0.1 to 0.5; 8 studies with 247 participants). No trials examined the short-term effects of stretch on quality of life or participation restrictions in people with neurological conditions. Five studies involving 145 participants reported eight adverse events including skin breakdown, bruising, blisters and pain but it was not possible to statistically analyse these data.In people with non-neurological conditions, there was high-quality evidence that stretch did not have clinically important short-term effects on pain (SMD -0.2, 95% CI -0.4 to 0.1; 7 studies with 422 participants) and moderate-quality evidence that stretch did not have clinically important short-term effects on quality of life (SMD 0.3, 95% CI -0.1 to 0.7; 2 studies with 97 participants). The short-term effect of stretch on activity limitations (SMD 0.1; 95% CI -0.2 to 0.3; 5 studies with 356 participants) and participation restrictions were uncertain (SMD -0.2; 95% CI -0.6 to 0.1; 2 studies with 192 participants). Nine studies involving 635 participants reported 41 adverse events including numbness, pain, Raynauds' phenomenon, venous thrombosis, need for manipulation under anaesthesia, wound infections, haematoma, flexion deficits and swelling but it was not possible to statistically analyse these data.
AUTHORS' CONCLUSIONS: There was high-quality evidence that stretch did not have clinically important effects on joint mobility in people with or without neurological conditions if performed for less than seven months. Sensitivity analyses indicate results were robust in studies at risk of selection and detection biases in comparison to studies at low risk of bias. Sub-group analyses also suggest the effect of stretch is consistent in people with different types of neurological or non-neurological conditions. The effects of stretch performed for periods longer than seven months have not been investigated. There was moderate- and high-quality evidence that stretch did not have clinically important short-term effects on quality of life or pain in people with non-neurological conditions, respectively. The short-term effects of stretch on quality of life and pain in people with neurological conditions, and the short-term effects of stretch on activity limitations and participation restrictions for people with and without neurological conditions are uncertain.
挛缩是神经和非神经疾病的常见并发症,其特征是关节活动度降低。伸展广泛用于挛缩的治疗和预防。然而,尚不清楚伸展是否有效。本综述是对2010年该综述原始版本的更新。
本综述的目的是确定伸展对患有挛缩或有挛缩风险的人群挛缩的影响。感兴趣的结局包括关节活动度、生活质量、疼痛、活动受限、参与限制、痉挛和不良事件。
2015年11月,我们检索了Cochrane系统评价数据库、DARE数据库、HTA数据库;MEDLINE数据库;Embase数据库;CINAHL数据库;科学引文索引扩展版数据库;PEDro数据库以及试验注册库。
我们纳入了为治疗或预防挛缩而应用伸展的随机对照试验和对照临床试验。
两位综述作者独立选择试验、提取数据并评估偏倚风险。感兴趣的结局包括关节活动度、生活质量、疼痛、活动受限、参与限制和不良事件。我们评估了短期(最后一次伸展后一周内)和长期(超过一周)的结局。我们将效应表示为平均差(MD)或标准化平均差(SMD),并给出95%置信区间(CI)。我们采用随机效应模型进行Meta分析。我们使用GRADE评估主要结局的证据质量。
49项研究共2135名参与者符合纳入标准。没有研究进行伸展超过7个月。略超过一半的研究(51%)存在选择偏倚的低风险;所有研究在自我报告结局如疼痛方面存在检测偏倚风险,且由于干预难以设盲存在实施偏倚风险。然而,大多数研究在客观结局包括运动范围方面存在检测偏倚的低风险,并且大多数研究没有失访和选择性报告偏倚。鉴于治疗几乎没有益处,这些偏倚的影响不太可能很重要。有高质量证据表明,伸展对患有神经疾病的人群(MD 2°;95%CI 0°至3°;26项研究,699名参与者)或非神经疾病的人群(SMD 0.2,95%CI 0至0.3;19项研究,925名参与者)的关节活动度在短期内没有临床重要影响。在患有神经疾病的人群中,伸展对疼痛(SMD 0.2;95%CI -0.1至0.